Christiane Smerling

Christiane Smerling

Company: 3B Pharmaceuticals

Job title: Head of Nuclear Medicine & Imaging


Christiane Smerling has been Head of Nuclear Medicine & Imaging at 3B Pharmaceuticals since it started operations in 2009. She has established 3BP’s radiopharmaceutical business and is responsible for 3BP’s theragnostic development programs. Her focus is the development of targeted radiopharmaceuticals and matching diagnostic imaging agents for oncology indications with high unmet medical need. She also manages the business development and partnering activities of 3BP’s Nuclear Medicine Division.

Prior to joining 3B Pharmaceuticals, Christiane worked as a scientist at Jerini AG. Christiane received her PhD from the University of Cambridge and her degree in biochemistry from the Freie Universität Berlin.


New solid tumor targets for targeted radiopharmaceutical therapy using peptides and small molecules 9:30 am

Different target classes Criteria a target has to meet How to identify a good target for a certain class of targeting molecules Potential pitfalls of peptides and small molecules 3BP’s hit identification platform Example of successful de novo hit generationRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.